Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation: A randomized, controlled trial

Annals of Internal Medicine

Volumn 135, Issue 6, 2001, Pages 423-433

  Hays, J T ^a   Hurt, R D ^a   Rigotti, N A ^a   Niaura, R ^a   Gonzales, D ^a   Durcan, M J ^a   Sachs, D P L ^a   Wolter, T D ^a   Buist, A S ^a   Johnston, J A ^a   White, J D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE;

ADULT; ARTICLE; BODY WEIGHT; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; RHINITIS; SMOKING; SMOKING CESSATION; SUSTAINED RELEASE PREPARATION; XEROSTOMIA;

EID: 0035909046     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-135-6-200109180-00011     Document Type: Article

References (26)

1. A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report
2. A comparison of sustained-release bupropion and placebo for smoking cessation
3. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
4. The effectiveness of the nicotine patch for smoking cessation. A meta-analysis
5. Preventing relapse to cigarette smoking by behavioral skill training
6. First lapses to smoking: Within-participants analysis of real-time reports
7. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment
8. Measuring nicotine dependence: A review of the Fagerström Tolerance Questionnaire
9. Signs and symptoms of tobacco withdrawal
10. Nonparametric estimation from incomplete observations
11. Regression models and life-tables
12. Efficacy of relapse prevention: A meta-analytic review
13. Weight gain as a function of smoking cessation and 2-mg nicotine gum use among middle-aged smokers with mild lung impairment in the first 2 years of the lung health study
14. Effects of differing nicotine-replacement doses on weight gain after smoking cessation
15. Randomised controlled trial of nasal nicotine spray in smoking cessation
16. A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation
17. Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials
18. Weight change after smoking cessation using variable doses of transdermal nicotine replacement
19. Issues in the prevention of weight gain after smoking cessation
20. Are weight concerns predictive of smoking cessation? A prospective analysis
21. Treatment options for the weight-conscious smoker
22. A 102-center prospective study of seizure in association with bupropion